Mini-antibodies found in the blood of camels, alpacas and llamas, shrunk further to create so-called "nanobodies," may help solve a problem in the cancer field: making specific types of T-cell therapies work in solid tumors. Scientists used these nanobodies -- which resemble antibodies in human blood -- to enhance the targeting abilities of the T-cell therapies. In tests with mice, the antibodies helped weaken the blood supply to tumors and targeted tumor-protecting proteins, thereby successfully curbing melanoma and colon cancer.
Credit: National Science Foundation/Karson Productions
Images and other media in the National Science Foundation Multimedia Gallery are available for use in print and electronic material by NSF employees, members of the media, university staff, teachers and the general public. All media in the gallery are intended for personal, educational and nonprofit/non-commercial use only.
Images credited to the National Science Foundation, a federal agency, are in the public domain. The images were created by employees of the United States Government as part of their official duties or prepared by contractors as "works for hire" for NSF. You may freely use NSF-credited images and, at your discretion, credit NSF with a "Courtesy: National Science Foundation" notation.
Additional information about general usage can be found in Conditions.